Fireside chat with Antoine Yver
Over several decades, Antoine Yver has worked on some of the most important cancer drugs currently available, most notably the big three at AstraZeneca: Tagrisso, Lynparza and Enhertu. His development work on Tagrisso stands out for its ultra-fast 2 year, 7 month long development period — from first dose to first approval. He and Editor John Carroll will talk about where the big cancer drugs of the future are coming from. And how long that takes.
![Antoine Yver](./assets/img/panelists/AntoineYver.jpg)
Antoine Yver
Chairman of Development, Director & Member of the Board
Centessa Pharmaceuticals Ltd, SANOFI
![John Carroll](./assets/img/panelists/JohnCarroll.jpg)
John Carroll
Editor & Founder